CPIX: +127.3%; Gets expanded labeling approval from FDA for Caldolor;
ADAG: +12.1%; Says FDA clears investigational New Drug Application for Phase 1b/2 study of ADG116 for cancer treatment;
ARCE: -2.8%; Swings to Q3 net loss as net revenue declines.
|Sierra Oncology Prices Upsized $135 Million Offering|
|Zymeworks Prices $100 Million Public Offering|
|Stellantis Plans to Take Majority Share in Joint Ven...|
|STMicroelectronics Posts Higher Q4 Earnings, Revenue|
|SAP to Buy Majority Stake in Working Capital Fintech...|